Kineret Mazor‐Aronovitch

751 total citations
32 papers, 506 citations indexed

About

Kineret Mazor‐Aronovitch is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Kineret Mazor‐Aronovitch has authored 32 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 12 papers in Surgery. Recurrent topics in Kineret Mazor‐Aronovitch's work include Diabetes Management and Research (16 papers), Diabetes and associated disorders (11 papers) and Pancreatic function and diabetes (10 papers). Kineret Mazor‐Aronovitch is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes and associated disorders (11 papers) and Pancreatic function and diabetes (10 papers). Kineret Mazor‐Aronovitch collaborates with scholars based in Israel, Australia and United States. Kineret Mazor‐Aronovitch's co-authors include Orit Pinhas‐Hamiel, Dalit Modan‐Moses, Heddy Landau, Noah Levek, Zohar Landau, David Gillis, Marianna Rachmiel, Ilana Koren, Yael Lebenthal and Avivit Brener and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Kineret Mazor‐Aronovitch

28 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kineret Mazor‐Aronovitch Israel 15 351 173 160 67 44 32 506
Bedowra Zabeen Bangladesh 12 355 1.0× 209 1.2× 155 1.0× 30 0.4× 60 1.4× 41 622
ManashP Baruah India 13 378 1.1× 92 0.5× 59 0.4× 22 0.3× 24 0.5× 51 535
Britta M. Svoren United States 10 356 1.0× 283 1.6× 216 1.4× 39 0.6× 45 1.0× 12 678
Archana Sadhu United States 12 464 1.3× 142 0.8× 245 1.5× 26 0.4× 11 0.3× 36 734
H. Overmann Germany 9 517 1.5× 172 1.0× 132 0.8× 45 0.7× 39 0.9× 11 661
Søren Friborg Denmark 11 219 0.6× 65 0.4× 56 0.3× 39 0.6× 48 1.1× 20 403
Soulmaz Fazeli Farsani Netherlands 11 366 1.0× 241 1.4× 130 0.8× 25 0.4× 88 2.0× 22 582
Kanhaiya Agrawal India 6 103 0.3× 60 0.3× 71 0.4× 27 0.4× 118 2.7× 14 416
Arthur Isnani Saudi Arabia 12 135 0.4× 58 0.3× 73 0.5× 16 0.2× 67 1.5× 34 505
Mariëlle A Schroijen Netherlands 9 267 0.8× 28 0.2× 123 0.8× 31 0.5× 15 0.3× 13 393

Countries citing papers authored by Kineret Mazor‐Aronovitch

Since Specialization
Citations

This map shows the geographic impact of Kineret Mazor‐Aronovitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kineret Mazor‐Aronovitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kineret Mazor‐Aronovitch more than expected).

Fields of papers citing papers by Kineret Mazor‐Aronovitch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kineret Mazor‐Aronovitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kineret Mazor‐Aronovitch. The network helps show where Kineret Mazor‐Aronovitch may publish in the future.

Co-authorship network of co-authors of Kineret Mazor‐Aronovitch

This figure shows the co-authorship network connecting the top 25 collaborators of Kineret Mazor‐Aronovitch. A scholar is included among the top collaborators of Kineret Mazor‐Aronovitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kineret Mazor‐Aronovitch. Kineret Mazor‐Aronovitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Demirbilek, Hüseyin, Sonya Galcheva, Mehmet Nuri Özbek, et al.. (2025). Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism. Med. 6(6). 100611–100611.
3.
4.
5.
Gruber, Noah, Michal Ben‐Ami, Kineret Mazor‐Aronovitch, et al.. (2023). Virtual reality's impact on children with type 1 diabetes: a proof-of-concept randomized cross-over trial on anxiety, pain, adherence, and glycemic control. Acta Diabetologica. 61(2). 215–224. 5 indexed citations
6.
Rachmiel, Marianna, Yael Lebenthal, Kineret Mazor‐Aronovitch, et al.. (2023). MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience. Diabetes Technology & Therapeutics. 25(9). 643–651. 10 indexed citations
7.
Mazor‐Aronovitch, Kineret, Orit Pinhas‐Hamiel, Dalit Modan‐Moses, et al.. (2021). Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder. Pediatric Diabetes. 22(4). 649–655. 9 indexed citations
8.
Levy‐Shraga, Yael, et al.. (2021). Effectiveness of Metformin for Weight Reduction in Children and Adolescents Treated with Mixed Dopamine and Serotonin Receptor Antagonists: A Naturalistic Cohort Study. Journal of Child and Adolescent Psychopharmacology. 31(5). 376–380. 2 indexed citations
9.
Rachmiel, Marianna, Yael Lebenthal, Kineret Mazor‐Aronovitch, et al.. (2021). Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?. Acta Diabetologica. 58(6). 697–705. 20 indexed citations
10.
Mazor‐Aronovitch, Kineret, Orit Pinhas‐Hamiel, Dalit Modan‐Moses, et al.. (2019). Dual Diagnosis of Type 1 Diabetes and ADHD. 92. 1 indexed citations
11.
12.
Rachmiel, Marianna, et al.. (2017). Bone Age Assessments by Quantitative Ultrasound (SonicBone) and Hand X-ray Based Methods are Comparable.. PubMed. 19(9). 533–538. 16 indexed citations
13.
14.
Rubinek, Tamar, Ayelet Shabtay‐Orbach, Yael Levy‐Shraga, et al.. (2016). Klotho response to treatment with growth hormone and the role of IGF-I as a mediator. Metabolism. 65(11). 1597–1604. 23 indexed citations
15.
Wolf, Ido, Yael Levy‐Shraga, Kineret Mazor‐Aronovitch, et al.. (2014). Association between Decreased Klotho Blood Levels and Organic Growth Hormone Deficiency in Children with Growth Impairment. PLoS ONE. 9(9). e107174–e107174. 20 indexed citations
16.
Levy‐Shraga, Yael, Liat Lerner‐Geva, V. Boyko, et al.. (2012). Type 1 diabetes in pre‐school children – long‐term metabolic control, associated autoimmunity and complications. Diabetic Medicine. 29(10). 1291–1296. 10 indexed citations
17.
Levy‐Shraga, Yael, Orit Pinhas‐Hamiel, Heddy Landau, et al.. (2012). Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism. Journal of Pediatric Endocrinology and Metabolism. 26(3-4). 301–8. 19 indexed citations
18.
Landau, Zohar, et al.. (2011). The effectiveness of Internet-based blood glucose monitoring system on improving diabetes control in adolescents with type 1 diabetes. Pediatric Diabetes. 13(2). 203–207. 38 indexed citations
19.
Modan‐Moses, Dalit, Ilana Koren, Kineret Mazor‐Aronovitch, Orit Pinhas‐Hamiel, & Heddy Landau. (2011). Treatment of Congenital Hyperinsulinism with Lanreotide Acetate (Somatuline Autogel). The Journal of Clinical Endocrinology & Metabolism. 96(8). 2312–2317. 47 indexed citations
20.
Mazor‐Aronovitch, Kineret, David Gillis, Harry J. Hirsch, et al.. (2007). Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. European Journal of Endocrinology. 157(4). 491–497. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bedowra Zabeen Breakdown of academic impact, for papers by ManashP Baruah Breakdown of academic impact, for papers by Britta M. Svoren Breakdown of academic impact, for papers by Archana Sadhu Breakdown of academic impact, for papers by H. Overmann Breakdown of academic impact, for papers by Søren Friborg Breakdown of academic impact, for papers by Soulmaz Fazeli Farsani Breakdown of academic impact, for papers by Kanhaiya Agrawal Breakdown of academic impact, for papers by Arthur Isnani Breakdown of academic impact, for papers by Mariëlle A Schroijen
Rankless by CCL
2026